Metastatic breast cancers: Estimates for Italy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.

Original languageEnglish
Pages (from-to)116-120
Number of pages5
JournalTumori
Volume104
Issue number2
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Italy
Breast Neoplasms
Recurrence
Mortality
Administrative Personnel
Breast
Incidence

Keywords

  • Breast cancer
  • Estimates
  • Italy
  • Metastasis
  • Stage IV

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metastatic breast cancers : Estimates for Italy. / Crocetti, Emanuele; Gori, Stefania; Falcini, Fabio.

In: Tumori, Vol. 104, No. 2, 01.01.2018, p. 116-120.

Research output: Contribution to journalArticle

Crocetti, Emanuele ; Gori, Stefania ; Falcini, Fabio. / Metastatic breast cancers : Estimates for Italy. In: Tumori. 2018 ; Vol. 104, No. 2. pp. 116-120.
@article{4a70f49a494645a88d5983eb8f22da14,
title = "Metastatic breast cancers: Estimates for Italy",
abstract = "Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1{\%} of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6{\%} of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.",
keywords = "Breast cancer, Estimates, Italy, Metastasis, Stage IV",
author = "Emanuele Crocetti and Stefania Gori and Fabio Falcini",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/0300891618766177",
language = "English",
volume = "104",
pages = "116--120",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Metastatic breast cancers

T2 - Estimates for Italy

AU - Crocetti, Emanuele

AU - Gori, Stefania

AU - Falcini, Fabio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.

AB - Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.

KW - Breast cancer

KW - Estimates

KW - Italy

KW - Metastasis

KW - Stage IV

UR - http://www.scopus.com/inward/record.url?scp=85050188495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050188495&partnerID=8YFLogxK

U2 - 10.1177/0300891618766177

DO - 10.1177/0300891618766177

M3 - Article

C2 - 29714648

AN - SCOPUS:85050188495

VL - 104

SP - 116

EP - 120

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -